SGLT2 inhibitors Empagliflozin: Empagliflozin is a novel SGLT2 inhibitor, the underlying mechanisms of which include ameliorating hyperglycemia, preventing the development of endothelial dysfunction, reducing oxidative stress, and improving metabolic profiles
Read More If you've been thinking about taking a GLP-1 (Glucagon Like Peptides 1) medication to lose weight, you may be wondering
Confidence scores are assigned to these associations, ranging from 1 star (low confidence) to 5 stars (high confidence)
It's a game-changer in a research context
It is known for angiogenesis, accelerated wound healing and cellular repair
[1] [3] The delayed gastric emptying may contribute to upper gastrointestinal symptoms, which could include burping or belching in some patients